Cargando…
Toxicology of Blister Agents: Is Melatonin a Potential Therapeutic Option?
Blister or vesicant chemical warfare agents (CWAs) have been widely used in different military conflicts, including World War I and the Iran-Iraq War. However, their mechanism of action is not fully understood. Sulfur and nitrogen mustard exert toxic effects not only through the alkylation of thiol-...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167553/ https://www.ncbi.nlm.nih.gov/pubmed/33920224 http://dx.doi.org/10.3390/diseases9020027 |
_version_ | 1783701714877022208 |
---|---|
author | Romero, Alejandro Ramos, Eva López-Muñoz, Francisco De Los Ríos, Cristóbal Egea, Javier Gil-Martín, Emilio Pita, René Torrado, Juan J. Serrano, Dolores R. Juberias, Antonio |
author_facet | Romero, Alejandro Ramos, Eva López-Muñoz, Francisco De Los Ríos, Cristóbal Egea, Javier Gil-Martín, Emilio Pita, René Torrado, Juan J. Serrano, Dolores R. Juberias, Antonio |
author_sort | Romero, Alejandro |
collection | PubMed |
description | Blister or vesicant chemical warfare agents (CWAs) have been widely used in different military conflicts, including World War I and the Iran-Iraq War. However, their mechanism of action is not fully understood. Sulfur and nitrogen mustard exert toxic effects not only through the alkylation of thiol-bearing macromolecules, such as DNA and proteins, but also produce free radicals that can develop direct toxic effects in target organs such as the eyes, skin, and respiratory system. The lack of effective treatments against vesicant CWAs-induced injury makes us consider, in this complex scenario, the use and development of melatonin-based therapeutic strategies. This multifunctional indoleamine could facilitate neutralization of the oxidative stress, modulate the inflammatory response, and prevent the DNA damage, as well as the long-term health consequences mediated by vesicant CWAs-induced epigenetic mechanisms. In this context, it would be essential to develop new galenic formulations for the use of orally and/or topically applied melatonin for the prophylaxis against vesicant CWAs, as well as the development of post-exposure treatments in the near future. |
format | Online Article Text |
id | pubmed-8167553 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81675532021-06-02 Toxicology of Blister Agents: Is Melatonin a Potential Therapeutic Option? Romero, Alejandro Ramos, Eva López-Muñoz, Francisco De Los Ríos, Cristóbal Egea, Javier Gil-Martín, Emilio Pita, René Torrado, Juan J. Serrano, Dolores R. Juberias, Antonio Diseases Review Blister or vesicant chemical warfare agents (CWAs) have been widely used in different military conflicts, including World War I and the Iran-Iraq War. However, their mechanism of action is not fully understood. Sulfur and nitrogen mustard exert toxic effects not only through the alkylation of thiol-bearing macromolecules, such as DNA and proteins, but also produce free radicals that can develop direct toxic effects in target organs such as the eyes, skin, and respiratory system. The lack of effective treatments against vesicant CWAs-induced injury makes us consider, in this complex scenario, the use and development of melatonin-based therapeutic strategies. This multifunctional indoleamine could facilitate neutralization of the oxidative stress, modulate the inflammatory response, and prevent the DNA damage, as well as the long-term health consequences mediated by vesicant CWAs-induced epigenetic mechanisms. In this context, it would be essential to develop new galenic formulations for the use of orally and/or topically applied melatonin for the prophylaxis against vesicant CWAs, as well as the development of post-exposure treatments in the near future. MDPI 2021-04-10 /pmc/articles/PMC8167553/ /pubmed/33920224 http://dx.doi.org/10.3390/diseases9020027 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Romero, Alejandro Ramos, Eva López-Muñoz, Francisco De Los Ríos, Cristóbal Egea, Javier Gil-Martín, Emilio Pita, René Torrado, Juan J. Serrano, Dolores R. Juberias, Antonio Toxicology of Blister Agents: Is Melatonin a Potential Therapeutic Option? |
title | Toxicology of Blister Agents: Is Melatonin a Potential Therapeutic Option? |
title_full | Toxicology of Blister Agents: Is Melatonin a Potential Therapeutic Option? |
title_fullStr | Toxicology of Blister Agents: Is Melatonin a Potential Therapeutic Option? |
title_full_unstemmed | Toxicology of Blister Agents: Is Melatonin a Potential Therapeutic Option? |
title_short | Toxicology of Blister Agents: Is Melatonin a Potential Therapeutic Option? |
title_sort | toxicology of blister agents: is melatonin a potential therapeutic option? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167553/ https://www.ncbi.nlm.nih.gov/pubmed/33920224 http://dx.doi.org/10.3390/diseases9020027 |
work_keys_str_mv | AT romeroalejandro toxicologyofblisteragentsismelatoninapotentialtherapeuticoption AT ramoseva toxicologyofblisteragentsismelatoninapotentialtherapeuticoption AT lopezmunozfrancisco toxicologyofblisteragentsismelatoninapotentialtherapeuticoption AT delosrioscristobal toxicologyofblisteragentsismelatoninapotentialtherapeuticoption AT egeajavier toxicologyofblisteragentsismelatoninapotentialtherapeuticoption AT gilmartinemilio toxicologyofblisteragentsismelatoninapotentialtherapeuticoption AT pitarene toxicologyofblisteragentsismelatoninapotentialtherapeuticoption AT torradojuanj toxicologyofblisteragentsismelatoninapotentialtherapeuticoption AT serranodoloresr toxicologyofblisteragentsismelatoninapotentialtherapeuticoption AT juberiasantonio toxicologyofblisteragentsismelatoninapotentialtherapeuticoption |